FXR and TGR5, as bile acid receptors, play an important role in renal water homeostasis through regulating the expression and trafficking of AQP2, which provides a novel therapeutic for the treatment of water and salt metabolism disorders such as diabetes insipidus (Figure 1). Here, AQP2 is linked to metabolic disease.